DCGI Approves AstraZeneca’s Drug for Treatment of High-risk Early Breast Cancer
On Friday, the Drugs Controller General of India (DCGI) has given its market approval to the drug Lynparza (Olaparib) as a monotherapy for the adjuvant...
Tag : DCGI (Drugs Controller General of India)
Zydus Seeks DCGI Nod to Undertake Clinical Trials for Monoclonal Antibodies Cocktail
Zydus has announced biological therapy ZRC-3308, used to treat mild COVID-19. The pharmaceutical company now seeks DCGI (Drugs Controller General of India) nod to undertake...